The launch of HealthCare.gov will likely always be remember for the numerous glitches and flaws that bogged down enrollment and the question of who is really to blame for the poor rollout remains.
The launch of HealthCare.gov will likely always be remember for the numerous glitches and flaws that bogged down enrollment and the question of who is really to blame for the poor rollout remains. However, a new report for the Office of the Inspector General (OIG) lays a large amount of blame squarely on CMS.
The “Federal Marketplace: Inadequacies in Contract Planning and Procurement” report from OIG determined that CMS did not prepare adequately for the launch of HealthCare.gov.
“The troubled launch of the Federal Marketplace at HealthCare.gov in October 2013 raised a number of concerns, including questions about the adequacy of CMS’s planning and procurement efforts for this key project under the Affordable Care Act,” according to the report.
OIG investigators reviewed documentation from CMS for the 60 contracts made to launch the federal Marketplace and selected 6 key contracts for in-depth review. They concluded that CMS did not always meet contracting requirements, such as developing an overarching acquisition strategy or performing all required oversight activities, when awarding contracts for the Marketplace.
OIG made 6 recommendations, all of with which HHS and CMS concurred:
“The complexity of the Federal Marketplace underscored the need for CMS to select the most qualified contractors,” the investigators wrote. “However, CMS did not perform thorough reviews of contractor past performance when awarding two key contracts.”
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More